Dr. Reddy’s gets 11 USFDA observations for Bachupally facility

29 Apr 2017 Evaluate

US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad on April 28, 2017. The company has been issued a Form 483 with 11 observations.

These observations are mostly procedural in nature, reflecting the need to improve people capabilities and strengthen documentation and laboratory systems. The pharma major will address them comprehensively within the stipulated time.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

6232.45 281.25 (4.73%)
25-Apr-2024 14:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.05
Dr. Reddys Lab 6232.45
Cipla 1406.40
Zydus Lifesciences 942.00
Lupin 1597.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.